Member Info for Sharedealer2019

The main difference is Novacyt was not a nationally recognised name, until now apart from the investors or previous investors the name has had limited exposure. This mention will bring new investors and press sniffing. No good having an amazing product if no one knows about you. To date it has been glaxo and AstraZeneca who have been talked about, now we are being mentioned with a government seal of approval!
Fantastic news! Great marketing and exposure!

‘World leading testing’ just mentioned, that’s us!

These will be the new labs to increase us over the 8 million numbers as described in previous RNS’s

Loving the mention for Novacyt! At last! Is this going to move at last the way it should!

Only way to unlock lockdown is testing!

‘Testing is crucial to get through this’
120,000 tested yesterday!

Chas I also hold small amount of Open Orphan, their testing lab is currently closed, at present they have not made money directly from Covid. Novacyt are the only company making sustained money and profits from Covid! Wake up people!

Elon his question was are any other Covid stocks making money, my answer was correct, no!
P.s I hold NCYT shares and SNG and have done since March. But again to answer his question, this is the only one making money directly from Covid.

In answer to your question no! But the investors on AIM seem to be looking for the multi bag! So if someone farts Covid they go running over there, headless chickens running all over Covid stocks! If this was a FTSE stock it would be three times the price and stable.

Jndavid490 am confused what America has to do with my post?

Should have said News at 10 BBC

Testing companies working flat out, ‘New commercial partnership due to deliver and extra 30,000 tests a day’, Pascal Soroit CEO Astra Zeneca then gives praise to the team working 24/7

Not new news but nice exposure!
Test Test Test

Hi Darien I wS contemplating taking more share......and based on your comment....AM GOING TO BUY! ZOOOOOOOM!

They did say they could increase but didn’t give figures
‘which provides greater contingency and the flexibility to scale- up its manufacturing outputs beyond eight million tests per month when necessary’

The RNS notifications normally shown on watchlist and on main page on here not flagging up an RNS....you physically have to go in....not saying this makes any difference but in my experience people track these to see where the news is...

Morning all, (big stretch)
What have I missed anything good? Just popping the lucky pants on.

Welcome, more than happy to help, just fingers crossed it’s us!

Apologies for delay had to rewind to listen to exact words....

He said ....‘Currently 6 clinical trials have been entered into national trials and the first is ready to enter the next stage a new early phase clinical trial platform that we are launching today’

What is your take on that Hardtohandle? Good or bad for us? And yes that’s an innocent question.